{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T19:56:37Z","timestamp":1794513397895,"version":"4.9.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T00:00:00Z","timestamp":1695600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T00:00:00Z","timestamp":1695600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010877","name":"Shenzhen Science and Technology Innovation Commission","doi-asserted-by":"publisher","award":["JCYJ20180507181627057"],"award-info":[{"award-number":["JCYJ20180507181627057"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007567","name":"City University of Hong Kong","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007567","id-type":"DOI","asserted-by":"publisher"}]},{"name":"RGC General Research Fund of Hong kong Special Administrative Region"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The crucial role of interferon (IFN) signaling is well known in the restriction or eradication of pathogen invasion. Viruses take a variety of ways to antagonize host defense through eliminating IFN-signaling intracellularly for decades. However, the way by viruses target IFN-signaling extracellularly has not been discovered. Infection by both coronavirus SARS-CoV-2 and enterovirus 71 (EV71 or EV-A71) can cause severe diseases such as neurological disorders and even death in children.<jats:sup>1\u20133<\/jats:sup> Here, we show evidence that the protease of SARS-CoV-2 (3CL<jats:sup>pro<\/jats:sup>) and EV71 (2A<jats:sup>pro<\/jats:sup>) upregulates the expression and secretion of LDL<jats:bold>-<\/jats:bold>receptor-related protein-associated protein 1 (LRPAP1). As a ligand, the N-terminus of secreted LRPAP1 binds with the extracellular domain of IFNAR1 that triggers the receptor ubiquitination and degradation and promotes virus infection both in vitro, ex vivo in the mouse brain, and in vivo in newborn mice. A small peptide from the N-terminus of LRPAP1 effectively binds and causes IFNAR1 degradation that enhances both DNA and RNA viral infections, including herpesvirus HSV-1, hepatitis B virus (HBV), EV71, and beta-coronavirus HCoV-OC43; whereas \u03b12M, a LRPAP1 inhibitor, arrests virus infections by stabilizing IFNAR1. Our study demonstrates a new mechanism used by viruses for evading host cell immunity, supporting a strategy for developing pan-antiviral drugs.<\/jats:p>","DOI":"10.1038\/s41392-023-01630-1","type":"journal-article","created":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T00:01:58Z","timestamp":1695600118000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Secreted LRPAP1 binds and triggers IFNAR1 degradation to facilitate virus evasion from cellular innate immunity"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1409-9219","authenticated-orcid":false,"given":"Huangcan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-Ting","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jufang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Liang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,25]]},"reference":[{"key":"1630_CR1","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1001\/jamaneurol.2021.0504","volume":"78","author":"KL LaRovere","year":"2021","unstructured":"LaRovere, K. L. et al. Neurologic involvement in children and adolescents hospitalized in the United States for COVID-19 or multisystem inflammatory syndrome. JAMA Neurol. 78, 536\u2013547 (2021).","journal-title":"JAMA Neurol."},{"key":"1630_CR2","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S2352-4642(21)00193-0","volume":"5","author":"STJ Ray","year":"2021","unstructured":"Ray, S. T. J. et al. Neurological manifestations of SARS-CoV-2 infection in hospitalised children and adolescents in the UK: a prospective national cohort study. Lancet Child Adolesc. Health 5, 631\u2013641 (2021).","journal-title":"Lancet Child Adolesc. Health"},{"key":"1630_CR3","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S1473-3099(10)70194-8","volume":"10","author":"T Solomon","year":"2010","unstructured":"Solomon, T. et al. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect. Dis. 10, 778\u2013790 (2010).","journal-title":"Lancet Infect. Dis."},{"key":"1630_CR4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000453397","volume":"9","author":"G Gasteiger","year":"2017","unstructured":"Gasteiger, G. et al. Cellular innate immunity: an old game with new players. J. Innate Immun. 9, 111\u2013125 (2017).","journal-title":"J. Innate Immun."},{"key":"1630_CR5","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1600-065X.2008.00737.x","volume":"227","author":"O Takeuchi","year":"2009","unstructured":"Takeuchi, O. & Akira, S. Innate immunity to virus infection. Immunol. Rev. 227, 75\u201386 (2009).","journal-title":"Immunol. Rev."},{"key":"1630_CR6","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/nature06246","volume":"449","author":"R Medzhitov","year":"2007","unstructured":"Medzhitov, R. Recognition of microorganisms and activation of the immune response. Nature 449, 819\u2013826 (2007).","journal-title":"Nature"},{"key":"1630_CR7","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","volume":"124","author":"S Akira","year":"2006","unstructured":"Akira, S., Uematsu, S. & Takeuchi, O. Pathogen recognition and innate immunity. Cell 124, 783\u2013801 (2006).","journal-title":"Cell"},{"key":"1630_CR8","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nri2174","volume":"7","author":"B Beutler","year":"2007","unstructured":"Beutler, B. et al. Genetic analysis of resistance to viral infection. Nat. Rev. Immunol. 7, 753\u2013766 (2007).","journal-title":"Nat. Rev. Immunol."},{"key":"1630_CR9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.chom.2008.11.008","volume":"5","author":"J Liu","year":"2009","unstructured":"Liu, J. et al. Virus-induced unfolded protein response attenuates antiviral defenses via phosphorylation-dependent degradation of the type I interferon receptor. Cell Host microbe 5, 72\u201383 (2009).","journal-title":"Cell Host microbe"},{"key":"1630_CR10","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.neuron.2013.04.005","volume":"78","author":"A Lampron","year":"2013","unstructured":"Lampron, A., ElAli, A. & Rivest, S. Innate Immunity in the CNS: redefining the relationship between the CNS and its environment. Neuron 78, 214\u2013232 (2013).","journal-title":"Neuron"},{"key":"1630_CR11","doi-asserted-by":"crossref","first-page":"110859","DOI":"10.1016\/j.biopha.2020.110859","volume":"132","author":"A Hosseini","year":"2020","unstructured":"Hosseini, A. et al. Innate and adaptive immune responses against coronavirus. Biomed. Pharmacother. 132, 110859 (2020).","journal-title":"Biomed. Pharmacother."},{"key":"1630_CR12","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1128\/JVI.02712-13","volume":"88","author":"Q Feng","year":"2014","unstructured":"Feng, Q. et al. Enterovirus 2Apro Targets MDA5 and MAVS in infected cells. J. Virol. 88, 3369\u20133378 (2014).","journal-title":"J. Virol."},{"key":"1630_CR13","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41392-020-00332-2","volume":"5","author":"Y Wu","year":"2020","unstructured":"Wu, Y. et al. Main protease of SARS-CoV-2 serves as a bifunctional molecule in restricting type I interferon antiviral signaling. Signal Transduct. Target Ther. 5, 221 (2020).","journal-title":"Signal Transduct. Target Ther."},{"key":"1630_CR14","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/s41564-019-0421-x","volume":"4","author":"EV Mesev","year":"2019","unstructured":"Mesev, E. V., LeDesma, R. A. & Ploss, A. Decoding type I and III interferon signalling during viral infection. Nat. Microbiol 4, 914\u2013924 (2019).","journal-title":"Nat. Microbiol"},{"key":"1630_CR15","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1073\/pnas.1525356113","volume":"113","author":"JR Teijaro","year":"2016","unstructured":"Teijaro, J. R. et al. S1PR1-mediated IFNAR1 degradation modulates plasmacytoid dendritic cell interferon-\u03b1 autoamplification. PNAS 113, 1351\u20131356 (2016).","journal-title":"PNAS"},{"key":"1630_CR16","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1128\/JVI.06687-11","volume":"86","author":"J Lu","year":"2012","unstructured":"Lu, J. et al. Enterovirus 71 disrupts interferon signaling by reducing the level of interferon receptor 1. J. Virol. 86, 3767\u20133776 (2012).","journal-title":"J. Virol."},{"key":"1630_CR17","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ajhg.2013.06.002","volume":"93","author":"MA Aldahmesh","year":"2013","unstructured":"Aldahmesh, M. A. et al. Mutations in LRPAP1 are associated with severe myopia in humans. Am. J. Hum. Genet 93, 313\u2013320 (2013).","journal-title":"Am. J. Hum. Genet"},{"key":"1630_CR18","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1601-183X.2008.00436.x","volume":"7","author":"P Pandey","year":"2008","unstructured":"Pandey, P., Pradhan, S. & Mittal, B. LRP-associated protein gene (LRPAP1) and susceptibility to degenerative dementia. Genes Brain Behav. 7, 943\u2013950 (2008).","journal-title":"Genes Brain Behav."},{"key":"1630_CR19","doi-asserted-by":"crossref","first-page":"17262","DOI":"10.1074\/jbc.M115.660084","volume":"290","author":"JM Prasad","year":"2015","unstructured":"Prasad, J. M., Migliorini, M., Galisteo, R. & Strickland, D. K. Generation of a potent low density lipoprotein receptor-related Protein 1 (LRP1) antagonist by engineering a stable form of the receptor-associated protein (RAP) D3 domain. J. Biol. Chem. 290, 17262\u201317268 (2015).","journal-title":"J. Biol. Chem."},{"key":"1630_CR20","doi-asserted-by":"crossref","first-page":"e1000719","DOI":"10.1371\/journal.ppat.1000719","volume":"6","author":"DL Diamond","year":"2010","unstructured":"Diamond, D. L. et al. Temporal proteome and lipidome profiles reveal Hepatitis C Virus-associated reprogramming of hepatocellular metabolism and bioenergetics. PLoS Pathog. 6, e1000719 (2010).","journal-title":"PLoS Pathog."},{"key":"1630_CR21","doi-asserted-by":"crossref","first-page":"3862","DOI":"10.1074\/jbc.M407435200","volume":"280","author":"FQ An","year":"2005","unstructured":"An, F. Q. et al. The latency-associated nuclear antigen of Kaposi\u2019s sarcoma-associated herpesvirus modulates cellular gene expression and protects lymphoid cells from p16 INK4A-induced cell cycle arrest. J. Biol. Chem. 280, 3862\u20133874 (2005).","journal-title":"J. Biol. Chem."},{"key":"1630_CR22","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1126\/science.7515194","volume":"264","author":"TE Willnow","year":"1994","unstructured":"Willnow, T. E., Sheng, Z., Ishibashi, S. & Herz, J. Inhibition of hepatic chylomicron remnant uptake by gene transfer of a receptor antagonist. Science 264, 1471\u20131474 (1994).","journal-title":"Science"},{"key":"1630_CR23","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1016\/j.devcel.2021.09.015","volume":"56","author":"W Bian","year":"2021","unstructured":"Bian, W. et al. Low-density-lipoprotein-receptor-related protein 1 mediates Notch pathway activation. Dev. Cell 56, 2902\u20132919.e2908 (2021).","journal-title":"Dev. Cell"},{"key":"1630_CR24","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1126\/science.abm2052","volume":"375","author":"S Spudich","year":"2022","unstructured":"Spudich, S. & Nath, A. Nervous system consequences of COVID-19. Science 375, 267\u2013269 (2022).","journal-title":"Science"},{"key":"1630_CR25","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1002\/1873-3468.12827","volume":"591","author":"J Lei","year":"2017","unstructured":"Lei, J. & Hilgenfeld, R. RNA-virus proteases counteracting host innate immunity. FEBS Lett. 591, 3190\u20133210 (2017).","journal-title":"FEBS Lett."},{"key":"1630_CR26","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s12985-014-0209-9","volume":"11","author":"K Matthews","year":"2014","unstructured":"Matthews, K., Sch\u00e4fer, A., Pham, A. & Frieman, M. The SARS coronavirus papain like protease can inhibit IRF3 at a post activation step that requires deubiquitination activity. Virol. J. 11, 209 (2014).","journal-title":"Virol. J."},{"key":"1630_CR27","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/s41579-021-00630-8","volume":"19","author":"H Yang","year":"2021","unstructured":"Yang, H. & Rao, Z. Structural biology of SARS-CoV-2 and implications for therapeutic development. Nat. Rev. Microbiol. 19, 685\u2013700 (2021).","journal-title":"Nat. Rev. Microbiol."},{"key":"1630_CR28","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3109\/1040841X.2011.580723","volume":"37","author":"L Yi","year":"2011","unstructured":"Yi, L., Lu, J., Kung, H. F. & He, M. L. The virology and developments toward control of human enterovirus 71. Crit. Rev. Microbiol. 37, 313\u2013327 (2011).","journal-title":"Crit. Rev. Microbiol."},{"key":"1630_CR29","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/emmm.201303236","volume":"6","author":"S Bhattacharya","year":"2014","unstructured":"Bhattacharya, S. et al. Triggering ubiquitination of IFNAR1 protects tissues from inflammatory injury. EMBO Mol. Med 6, 384\u2013397 (2014).","journal-title":"EMBO Mol. Med"},{"key":"1630_CR30","doi-asserted-by":"crossref","first-page":"22069","DOI":"10.1074\/jbc.M111.238766","volume":"286","author":"S Bhattacharya","year":"2011","unstructured":"Bhattacharya, S. et al. Role of p38 protein kinase in the ligand-independent ubiquitination and down-regulation of the IFNAR1 chain of type I interferon receptor. J. Biol. Chem. 286, 22069\u201322076 (2011).","journal-title":"J. Biol. Chem."},{"key":"1630_CR31","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13476","volume":"7","author":"D Chmiest","year":"2016","unstructured":"Chmiest, D. et al. Spatiotemporal control of interferon-induced JAK\/STAT signalling and gene transcription by the retromer complex. Nat. Commun. 7, 13476 (2016).","journal-title":"Nat. Commun."},{"key":"1630_CR32","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.chom.2017.07.012","volume":"22","author":"A Garc\u00eda-Sastre","year":"2017","unstructured":"Garc\u00eda-Sastre, A. Ten strategies of interferon evasion by viruses. Cell Host microbe 22, 176\u2013184 (2017).","journal-title":"Cell Host microbe"},{"key":"1630_CR33","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1089\/jir.2009.0078","volume":"29","author":"M Gale Jr","year":"2009","unstructured":"Gale, M. Jr & Sen, G. C. Viral evasion of the interferon system. J. Interferon Cytokine Res. 29, 475\u2013476 (2009).","journal-title":"J. Interferon Cytokine Res."},{"key":"1630_CR34","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1126\/science.abj7965","volume":"374","author":"J-L Casanova","year":"2021","unstructured":"Casanova, J.-L. & Abel, L. Mechanisms of viral inflammation and disease in humans. Science 374, 1080\u20131086 (2021).","journal-title":"Science"},{"key":"1630_CR35","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41577-020-0346-x","volume":"20","author":"D Acharya","year":"2020","unstructured":"Acharya, D., Liu, G. & Gack, M. U. Dysregulation of type I interferon responses in COVID-19. Nat. Rev. Immunol. 20, 397\u2013398 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"1630_CR36","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1074\/mcp.M900180-MCP200","volume":"8","author":"Y Ma","year":"2009","unstructured":"Ma, Y. et al. Glucose-regulated protein 78 is an intracellular antiviral factor against hepatitis B virus. Mol. Cell Proteom. 8, 2582\u20132594 (2009).","journal-title":"Mol. Cell Proteom."},{"key":"1630_CR37","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.neuropharm.2008.05.016","volume":"55","author":"Z Sheng","year":"2008","unstructured":"Sheng, Z., Prorok, M., Brown, B. E. & Castellino, F. J. N-methyl-D-aspartate receptor inhibition by an apolipoprotein E-derived peptide relies on low-density lipoprotein receptor-associated protein. Neuropharmacology 55, 204\u2013214 (2008).","journal-title":"Neuropharmacology"},{"key":"1630_CR38","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1073\/pnas.1515480113","volume":"113","author":"E Mantuano","year":"2016","unstructured":"Mantuano, E. et al. LDL receptor-related protein-1 regulates NFkappaB and microRNA-155 in macrophages to control the inflammatory response. PNAS 113, 1369\u20131374 (2016).","journal-title":"PNAS"},{"key":"1630_CR39","doi-asserted-by":"crossref","first-page":"e2729","DOI":"10.1371\/journal.pone.0002729","volume":"3","author":"MF Galliano","year":"2008","unstructured":"Galliano, M. F. et al. Binding of alpha2ML1 to the low density lipoprotein receptor-related protein 1 (LRP1) reveals a new role for LRP1 in the human epidermis. PLoS One 3, e2729 (2008).","journal-title":"PLoS One"},{"key":"1630_CR40","doi-asserted-by":"crossref","first-page":"26172","DOI":"10.1016\/S0021-9258(18)35732-6","volume":"267","author":"T Willnow","year":"1993","unstructured":"Willnow, T., Goldstein, J., Orth, K., Brown, M. & Herz, J. Low density lipoprotein receptor-related protein and gp330 bind similar ligands, including plasminogen activator-inhibitor complexes and lactoferrin, an inhibitor of chylomicron remnant clearance. J. Biol. Chem. 267, 26172\u201326180 (1993).","journal-title":"J. Biol. Chem."},{"key":"1630_CR41","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.antiviral.2017.11.020","volume":"150","author":"Q Dong","year":"2018","unstructured":"Dong, Q. et al. Hsc70 regulates the IRES activity and serves as an antiviral target of enterovirus A71 infection. Antivir. Res. 150, 39\u201346 (2018).","journal-title":"Antivir. Res."},{"key":"1630_CR42","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.isci.2019.08.008","volume":"19","author":"F Zhou","year":"2019","unstructured":"Zhou, F. et al. Pim1 impacts enterovirus A71 replication and represents a potential target in antiviral therapy. iScience 19, 715\u2013727 (2019).","journal-title":"iScience"},{"key":"1630_CR43","doi-asserted-by":"crossref","first-page":"e0092221","DOI":"10.1128\/JVI.00922-21","volume":"95","author":"S Fan","year":"2021","unstructured":"Fan, S., Xu, Z., Liu, P., Qin, Y. & Chen, M. Enterovirus 71 2A protease inhibits P-body formation to promote viral RNA synthesis. J. Virol. 95, e0092221 (2021).","journal-title":"J. Virol."},{"key":"1630_CR44","first-page":"709853","volume":"2012","author":"EI P\u00e9cheur","year":"2012","unstructured":"P\u00e9cheur, E. I. Lipoprotein receptors and lipid enzymes in hepatitis C virus entry and early steps of infection. Sci. (Cairo) 2012, 709853 (2012).","journal-title":"Sci. (Cairo)"},{"key":"1630_CR45","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jcmgh.2023.03.011","volume":"16","author":"K Esser","year":"2023","unstructured":"Esser, K. et al. Hepatitis B virus targets lipid transport pathways to infect hepatocytes. Cell Mol. Gastroenterol. Hepatol. 16, 201\u2013221 (2023).","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"1630_CR46","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/s42255-020-00324-0","volume":"2","author":"C Wei","year":"2020","unstructured":"Wei, C. et al. HDL-scavenger receptor B type 1 facilitates SARS-CoV-2 entry. Nat. Metab. 2, 1391\u20131400 (2020).","journal-title":"Nat. Metab."},{"key":"1630_CR47","doi-asserted-by":"crossref","first-page":"108234","DOI":"10.1016\/j.celrep.2020.108234","volume":"33","author":"H Xia","year":"2020","unstructured":"Xia, H. et al. Evasion of Type I Interferon by SARS-CoV-2. Cell Rep. 33, 108234 (2020).","journal-title":"Cell Rep."},{"key":"1630_CR48","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.virol.2018.06.017","volume":"522","author":"C Xia","year":"2018","unstructured":"Xia, C., Anderson, P. & Hahm, B. Viral dedication to vigorous destruction of interferon receptors. Virology 522, 19\u201326 (2018).","journal-title":"Virology"},{"key":"1630_CR49","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1038\/nm.4211","volume":"22","author":"A Jarret","year":"2016","unstructured":"Jarret, A. et al. Hepatitis-C-virus-induced microRNAs dampen interferon-mediated antiviral signaling. Nat. Med. 22, 1475\u20131481 (2016).","journal-title":"Nat. Med."},{"key":"1630_CR50","first-page":"e01148","volume":"91","author":"R Zhang","year":"2017","unstructured":"Zhang, R. et al. Pseudorabies virus dUTPase UL50 induces lysosomal degradation of Type I interferon Receptor 1 and antagonizes the alpha interferon response. J. Virol. 91, e01148\u201317 (2017).","journal-title":"J. Virol."},{"key":"1630_CR51","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1002\/art.38576","volume":"66","author":"S Wang","year":"2014","unstructured":"Wang, S. et al. Identification of \u03b12-macroglobulin as a master inhibitor of cartilage-degrading factors that attenuates the progression of posttraumatic osteoarthritis. Arthritis Rheumatol. 66, 1843\u20131853 (2014).","journal-title":"Arthritis Rheumatol."},{"key":"1630_CR52","doi-asserted-by":"crossref","first-page":"33352","DOI":"10.1074\/jbc.M109.015032","volume":"284","author":"T Kanekiyo","year":"2009","unstructured":"Kanekiyo, T. & Bu, G. Receptor-associated protein interacts with Amyloid-\u03b2 peptide and promotes its cellular uptake. J. Biol. Chem. 284, 33352\u201333359 (2009).","journal-title":"J. Biol. Chem."},{"key":"1630_CR53","doi-asserted-by":"crossref","first-page":"5410657","DOI":"10.1155\/2019\/5410657","volume":"2019","author":"JH Cater","year":"2019","unstructured":"Cater, J. H., Wilson, M. R. & Wyatt, A. R. Alpha-2-Macroglobulin, a hypochlorite-regulated chaperone and immune system modulator. Oxid. Med Cell Longev. 2019, 5410657 (2019).","journal-title":"Oxid. Med Cell Longev."},{"key":"1630_CR54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40610-020-00142-z","volume":"7","author":"M Zhu","year":"2021","unstructured":"Zhu, M., Zhao, B., Wei, L. & Wang, S. alpha-2-Macroglobulin, a native and powerful proteinase inhibitor, prevents cartilage degeneration disease by inhibiting majority of catabolic enzymes and cytokines. Curr. Mol. Biol. Rep. 7, 1\u20137 (2021).","journal-title":"Curr. Mol. Biol. Rep."},{"key":"1630_CR55","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1042\/bj3410377","volume":"341","author":"A Sato","year":"1999","unstructured":"Sato, A., Shimada, Y., Herz, J., Yamamoto, T. & Jingami, H. 39-kDa receptor-associated protein (RAP) facilitates secretion and ligand binding of extracellular region of very-low-density-lipoprotein receptor: implications for a distinct pathway from low-density-lipoprotein receptor. Biochem J. 341, 377\u2013383 (1999).","journal-title":"Biochem J."},{"key":"1630_CR56","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.neulet.2006.01.040","volume":"400","author":"C Depboylu","year":"2006","unstructured":"Depboylu, C. et al. Alpha2-macroglobulin, lipoprotein receptor-related protein and lipoprotein receptor-associated protein and the genetic risk for developing Alzheimer\u2019s disease. Neurosci. Lett. 400, 187\u2013190 (2006).","journal-title":"Neurosci. Lett."},{"key":"1630_CR57","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1172\/JCI4164","volume":"102","author":"MM V\u00e9niant","year":"1998","unstructured":"V\u00e9niant, M. M. et al. Lipoprotein clearance mechanisms in LDL receptor-deficient \u201cApo-B48-only\u201d and \u201cApo-B100-only\u201d mice. J. Clin. Invest 102, 1559\u20131568 (1998).","journal-title":"J. Clin. Invest"},{"key":"1630_CR58","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1194\/jlr.M200129-JLR200","volume":"43","author":"TM Riddle","year":"2002","unstructured":"Riddle, T. M., Schildmeyer, N. M., Phan, C., Fichtenbaum, C. J. & Hui, D. Y. The HIV protease inhibitor ritonavir increases lipoprotein production and has no effect on lipoprotein clearance in mice. J. Lipid Res 43, 1458\u20131463 (2002).","journal-title":"J. Lipid Res"},{"key":"1630_CR59","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41392-021-00786-y","volume":"6","author":"F Zhou","year":"2021","unstructured":"Zhou, F. et al. Attenuating innate immunity and facilitating beta-coronavirus infection by NSP1 of SARS-CoV-2 through specific redistributing hnRNP A2\/B1 cellular localization. Signal Transduct. Target Ther. 6, 371 (2021).","journal-title":"Signal Transduct. Target Ther."},{"key":"1630_CR60","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1038\/s41467-020-17011-z","volume":"11","author":"L Evgin","year":"2020","unstructured":"Evgin, L. et al. Oncolytic virus-derived type I interferon restricts CAR T cell therapy. Nat. Commun. 11, 3187\u20133187 (2020).","journal-title":"Nat. Commun."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-023-01630-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-023-01630-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-023-01630-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T01:07:05Z","timestamp":1700528825000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-023-01630-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,25]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1630"],"URL":"https:\/\/doi.org\/10.1038\/s41392-023-01630-1","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,25]]},"assertion":[{"value":"29 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.L.H., H.L. and X.W. are inventors of US patent application no. 63\/500,277 in May 2023. Title: Method of use LRPAP1 inhibitors against multiple virus infections. The others declare no competing interests. M.L.H. is one of the editorial board members in <i>Signal Transduction and Targeted Therapy<\/i> and he has not been involved in the process of the manuscript handling.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"374"}}